Company Search:
Advanced Search
Sponsored Links
Siegfried Holding AG Company Snapshot
Siegfried Holding AG operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Siegfried Holding AG with three other pharmaceutical manufacturers in Europe: Almirall SA of Spain (2018 sales of 756.93 million Euro [US$838.24 million] of which 67% was Own Network (Spain)), Diasorin S.P.A. of Italy (669.20 million Euro [US$741.08 million] of which 100% was Operating), and Guerbet SA which is based in France (789.60 million Euro [US$874.42 million] of which 44% was X-rays).

Sales Analysis. Siegfried Holding AG reported sales of 794.30 million Swiss Francs (US$799.90 million) for the year ending December of 2018. This represents an increase of 5.8% versus 2017, when the company's sales were 750.47 million Swiss Francs. This was the fourth straight year of sales growth at Siegfried Holding AG. Sales of Drug Products saw an increase that was more than double the company's growth rate: sales were up 17.1% in 2018, from 169.80 million Swiss Francs to 198.80 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Siegfried Holding AG
  Stock Performance Chart for Siegfried Holding AG
  Stock Data: Recent Stock Performance:
  Current Price (9/20/2019): 417.50
(Figures in Swiss Francs)
1 Week 2.8%   13 Weeks 2.7%  
4 Weeks 19.1%   52 Weeks -8.7%  
Siegfried Holding AG Key Data:
  Ticker: SFZN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2018 Sales 794,297,000
(Year Ending Jan 2019).
Employees: 2,294
  Currency: Swiss Francs Market Cap: 1,739,633,990
  Fiscal Yr Ends: December Shares Outstanding: 4,166,788
  Share Type: Namenaktie Closely Held Shares: 143,940
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.